Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06852638 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CD70-targeted immunoPET Imaging of Malignant Cancers

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase: Not applicable to Phase 2v2 Show 5 more changesShow less
    • Primary endpoints: 10 to 2
    • Primary and study completion dates: Dec 2026 to Dec 23, 2026
    • Interventions: [18F]F-RESCA-R8B4 (Drug), [18F]F-RESCA-RCCB6 (Drug), [18F]F-RESCA-RD06 (Drug), [68Ga]Ga-NOTA-R8B4 (Drug), [68Ga]Ga-NOTA-RD06 (Drug)… to [18F]F-RESCA-R8B4 (Drug), [18F]F-RESCA-RCCB6 (Drug), [18F]F-RESCA-RD06 (Drug), [68Ga]Ga-NOTA-R8B4 (Drug), [68Ga]Ga-NOTA-RD06 (Drug)
    • Secondary endpoints: 4 to 1
    • Study description expanded, about 24 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
RenJi Hospital
190 trials monitored
See 2 trials at risk
Head & Neck Cancer
2,605 trials monitored
See 150 trials at risk
Non-Hodgkin Lymphoma
2,013 trials monitored
See 115 trials at risk
Kidney Cancer
889 trials monitored
See 68 trials at risk
and 3 more diseases
This study aims to determine the value of cluster of differentiation (CD70)-targeted immuno-positron emission tomography/computed tomography (immunoPET/CT) imaging for diagnosing human malignancies, including renal cell carcinoma (particularly clear cell renal cell carcinoma), lymphoma, and nasopharyngeal carcinoma (NPC), among others.
Trial Details
NCT Number NCT06852638
Lead Sponsor RenJi Hospital
Conditions
(from sponsor)		 Renal Cancer, Renal Clear Cell Carcinoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma, Mantle Cell Lymphoma, Nasopharyngeal Carcinoma
Related terms Carcinoma, Renal Cell, Kidney Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Nasopharyngeal Carcinoma
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov